-transparent.png){kind=logo}
The difficulty of instituting an efficacious therapy against Pseudomonas aeruginosa infections is principally due to the microorganism's antibiotic resistance. The aim of our study was to evaluate the activity of four antibacterial drugs, two penems and two quinolones, on the production of virulence factors. Our results demonstrated that the antibiotics tested have a different behaviour depending on the P. aeruginosa phenotype. Therefore it would be advisable to choose the drug on the basis of the isolated strain phenotype.
Related Publications
P Cipriani, and
M Trancassini, and
M R Chiossi, and
D De Vito, and
F Filadoro
April 1986,
Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology,
P Cipriani, and
M Trancassini, and
M R Chiossi, and
D De Vito, and
F Filadoro
November 2021,
Antibiotics (Basel, Switzerland),
P Cipriani, and
M Trancassini, and
M R Chiossi, and
D De Vito, and
F Filadoro
September 2020,
Microbial pathogenesis,
P Cipriani, and
M Trancassini, and
M R Chiossi, and
D De Vito, and
F Filadoro
May 1993,
The Journal of antimicrobial chemotherapy,
P Cipriani, and
M Trancassini, and
M R Chiossi, and
D De Vito, and
F Filadoro
January 2020,
Infection and drug resistance,
P Cipriani, and
M Trancassini, and
M R Chiossi, and
D De Vito, and
F Filadoro
January 2021,
Saudi journal of biological sciences,
P Cipriani, and
M Trancassini, and
M R Chiossi, and
D De Vito, and
F Filadoro
December 1989,
The Journal of antimicrobial chemotherapy,
P Cipriani, and
M Trancassini, and
M R Chiossi, and
D De Vito, and
F Filadoro
July 2013,
BMC microbiology,
P Cipriani, and
M Trancassini, and
M R Chiossi, and
D De Vito, and
F Filadoro
June 2018,
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
P Cipriani, and
M Trancassini, and
M R Chiossi, and
D De Vito, and
F Filadoro
January 2021,
PloS one,
